NL181553B - METHOD FOR PREPARING A VIRUS SUB-UNIT VACCINE - Google Patents

METHOD FOR PREPARING A VIRUS SUB-UNIT VACCINE

Info

Publication number
NL181553B
NL181553B NLAANVRAGE7413642,A NL7413642A NL181553B NL 181553 B NL181553 B NL 181553B NL 7413642 A NL7413642 A NL 7413642A NL 181553 B NL181553 B NL 181553B
Authority
NL
Netherlands
Prior art keywords
preparing
unit vaccine
virus sub
virus
sub
Prior art date
Application number
NLAANVRAGE7413642,A
Other languages
Dutch (nl)
Other versions
NL7413642A (en
NL181553C (en
Original Assignee
Flockhart & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flockhart & Co filed Critical Flockhart & Co
Publication of NL7413642A publication Critical patent/NL7413642A/en
Publication of NL181553B publication Critical patent/NL181553B/en
Application granted granted Critical
Publication of NL181553C publication Critical patent/NL181553C/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17Newcastle disease virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16251Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18111Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18111Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18151Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NLAANVRAGE7413642,A 1973-10-18 1974-10-17 METHOD FOR PREPARING A VIRUS SUB-UNIT VACCINE NL181553C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB48685/73A GB1486557A (en) 1973-10-18 1973-10-18 Process for the preparation of pyrogen-free sub-unit vaccine

Publications (3)

Publication Number Publication Date
NL7413642A NL7413642A (en) 1975-04-22
NL181553B true NL181553B (en) 1987-04-16
NL181553C NL181553C (en) 1987-09-16

Family

ID=10449549

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7413642,A NL181553C (en) 1973-10-18 1974-10-17 METHOD FOR PREPARING A VIRUS SUB-UNIT VACCINE

Country Status (15)

Country Link
JP (1) JPS5082228A (en)
AT (1) AT334524B (en)
BE (1) BE821175A (en)
CA (1) CA1050886A (en)
CH (1) CH611518A5 (en)
DE (1) DE2449530C2 (en)
DK (1) DK138581B (en)
FR (1) FR2248054B1 (en)
GB (1) GB1486557A (en)
IE (1) IE40187B1 (en)
IL (1) IL45870A (en)
NL (1) NL181553C (en)
NO (1) NO142024C (en)
SE (1) SE426439B (en)
ZA (1) ZA746398B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK276380A (en) * 1979-07-09 1981-01-10 Univ Iowa State Res Found Inc PROCEDURE FOR THE PREPARATION OF A VACCINE AGAINST INFECTIOUS KVEG-RHINOTRACHEITIS
FR2470795A1 (en) * 1979-12-07 1981-06-12 Pasteur Institut PROCESS FOR THE PURIFICATION OF PARTICLES OF BIOLOGICAL ORIGIN, IN PARTICULAR OF THE SURFACE ANTIGEN OF HEPATITIS B VIRUS (AGHBS) AND THE PRODUCTS OBTAINED
FR2475572A1 (en) * 1980-02-11 1981-08-14 Pasteur Institut PROCESS FOR OBTAINING LIPID ENVELOPE VIRUS FRAGMENTS, PARTICULARLY ANTIGENS USED AS VACCINES, PRODUCTS OBTAINED AND APPLICATIONS
FR2483779A1 (en) 1980-06-05 1981-12-11 Synthelabo PROCESS FOR ISOLATING VIRAL GLYCOPROTETIC ANTIGENS AND APPLICATION THEREOF TO VACCINE PREPARATION
DE19938767C2 (en) * 1999-08-16 2002-10-24 Tad Pharma Gmbh subunit vaccines
CN1253207C (en) * 2000-10-02 2006-04-26 葛兰素史密丝克莱恩生物有限公司 Split enveloped virus preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519400A (en) * 1967-01-25 1970-07-07 Atomic Energy Commission Method of centrifugal separation and recovery of chemical species utilizing a liquid medium

Also Published As

Publication number Publication date
DK543974A (en) 1975-06-16
FR2248054A1 (en) 1975-05-16
CH611518A5 (en) 1979-06-15
NL7413642A (en) 1975-04-22
SE7413113L (en) 1975-04-21
NO142024B (en) 1980-03-10
DE2449530C2 (en) 1985-08-08
NL181553C (en) 1987-09-16
DK138581C (en) 1979-03-12
GB1486557A (en) 1977-09-21
IE40187B1 (en) 1979-03-28
AU7444974A (en) 1976-04-29
CA1050886A (en) 1979-03-20
AT334524B (en) 1976-01-25
FR2248054B1 (en) 1978-07-28
IL45870A (en) 1978-03-10
DE2449530A1 (en) 1975-04-30
ATA835074A (en) 1976-05-15
BE821175A (en) 1975-04-17
DK138581B (en) 1978-10-02
NO142024C (en) 1980-06-18
JPS5082228A (en) 1975-07-03
IE40187L (en) 1975-04-18
SE426439B (en) 1983-01-24
NO743758L (en) 1975-05-12
ZA746398B (en) 1976-06-30
IL45870A0 (en) 1974-12-31

Similar Documents

Publication Publication Date Title
NL182369C (en) METHOD FOR PREPARING AN ORAL EXTENDED MEDICINE PREPARATION
NL7415978A (en) PROCEDURE FOR PREPARING A CRACK CATALYST.
NL7414050A (en) PROCESS FOR PREPARING A TISSUE PROCESSING PREPARATION.
NL7416345A (en) PROCEDURE FOR PREPARING A CATALYST ON A SUPPORT AND CATALYST ON A SUPPORT, PREPARED BY THE PROCESS.
NL178085C (en) METHOD FOR PREPARING AN IMPROVED ADHESIVE
NL7415793A (en) PROCESS FOR PREPARING A PIPERAZI NYLCHINAZOLINE.
NL163135C (en) METHOD FOR PREPARING A CATALYST
NL7411312A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION.
NL164184C (en) METHOD FOR PREPARING AN INSECTICIDE PREPARATION.
NL179447C (en) METHOD FOR PREPARING A FOOD
NL159679B (en) METHOD FOR PREPARING POLYLACTONES.
NL171061C (en) PROCESS FOR PREPARING A JUMPER
NL7409809A (en) PROCEDURE FOR PREPARING A MULTIVITA MINE PREPARATION.
NL176186C (en) METHOD FOR PREPARING A SOLID ISOHUMULONE PREPARATION
NL179731B (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS WITH ACTION ON THE CARDIOVASCULAR SYSTEM, AND A PROCESS FOR PREPARING 3-PIPERIDINO-ALKYL-ATLICO-DERIVATED-DERIVATOL-DERIVATOL-PREPARATANO PREPARATES.
NL180902C (en) METHOD FOR PREPARING ARTIFICIAL MEAT.
NL174009C (en) METHOD FOR PREPARING A CONCENTRATED AGENT FOR STABLE INFECTION
NL181553C (en) METHOD FOR PREPARING A VIRUS SUB-UNIT VACCINE
NL185824C (en) METHOD FOR PREPARING A PHARMACEUTICAL DOSAGE UNIT
NL7415614A (en) INFLUENZA ACCINES AND METHOD FOR PREPARING THEM
NL7413323A (en) PROCESS FOR THE PREPARATION OF A VETERINARY PREPARATION.
NL7410876A (en) PROCESS FOR THE PREPARATION OF A DESULFUSION CATALYST.
NL179542C (en) METHOD FOR PREPARING AN ANTHELMINTIC PREPARATION
NL7412493A (en) PROCESS FOR PREPARING A FOOD FOR RUMINS.
NL7409394A (en) TRIFLUORMETHYL-SUBSTITUTED AMINOARYLSULFO-NYL COMPOUNDS AND A METHOD FOR PREPARING THEM.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
SNR Assignments of patents or rights arising from examined patent applications

Owner name: EVANS MEDICAL LIMITED

V4 Discontinued because of reaching the maximum lifetime of a patent